FDA Panel Advocates Easing Peptide Restrictions Amid Scientific Concerns Business July 24, 2026 The FDA’s advisory committee has voted narrowly to ease restrictions on certain peptides, despite strong opposition from agency scientists. During…
US Regulators to Reassess Controversial Peptide with Backing from RFK Jr. Business July 22, 2026 The popularity of peptides—compounds increasingly marketed for promoting sleep, muscle growth, and anti-aging—is on the rise, prompting scrutiny from the…
